title: Can we boost enough without ritonavir?
authors.affiliation: Chelsea & Westminster Hospital, London, UK.
authors.forename: Marta
authors.initials: M
authors.lastname: Boffito
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Moyle
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000494:pharmacology; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D016527:Drug Costs; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000191:economics / Q000494:pharmacology; D006801:Humans; D019438:Ritonavir / Q000008:administration & dosage / Q000191:economics; D013810:Therapeutic Equivalency
chemical_list: D000276:Adjuvants, Immunologic; D065607:Cytochrome P-450 Enzyme Inhibitors; D017320:HIV Protease Inhibitors; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D019438:Ritonavir